NANOREPRO AG (NN6.DE) Fundamental Analysis & Valuation

FRA:NN6 • DE0006577109

Current stock price

1.415 EUR
-0.03 (-2.41%)
Last:

This NN6.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NN6.DE Profitability Analysis

1.1 Basic Checks

  • NN6 had negative earnings in the past year.
  • In multiple years NN6 reported negative net income over the last 5 years.
  • In multiple years NN6 reported negative operating cash flow during the last 5 years.
NN6.DE Yearly Net Income VS EBIT VS OCF VS FCFNN6.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

1.2 Ratios

  • NN6's Return On Assets of -4.54% is on the low side compared to the rest of the industry. NN6 is outperformed by 65.08% of its industry peers.
  • NN6's Return On Equity of -4.62% is on the low side compared to the rest of the industry. NN6 is outperformed by 63.49% of its industry peers.
Industry RankSector Rank
ROA -4.54%
ROE -4.62%
ROIC N/A
ROA(3y)-8.02%
ROA(5y)5.73%
ROE(3y)-8.27%
ROE(5y)9.6%
ROIC(3y)N/A
ROIC(5y)N/A
NN6.DE Yearly ROA, ROE, ROICNN6.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • NN6 has a Gross Margin of 59.36%. This is comparable to the rest of the industry: NN6 outperforms 53.97% of its industry peers.
  • NN6's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for NN6 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.22%
GM growth 5Y-10.72%
NN6.DE Yearly Profit, Operating, Gross MarginsNN6.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. NN6.DE Health Analysis

2.1 Basic Checks

  • NN6 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • NN6 has less shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, NN6 has more shares outstanding
  • NN6 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NN6.DE Yearly Shares OutstandingNN6.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NN6.DE Yearly Total Debt VS Total AssetsNN6.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • NN6 has an Altman-Z score of 16.09. This indicates that NN6 is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 16.09, NN6 belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
  • NN6 has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 16.09
ROIC/WACCN/A
WACC7.45%
NN6.DE Yearly LT Debt VS Equity VS FCFNN6.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

  • A Current Ratio of 32.12 indicates that NN6 has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 32.12, NN6 belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • NN6 has a Quick Ratio of 30.20. This indicates that NN6 is financially healthy and has no problem in meeting its short term obligations.
  • NN6 has a better Quick ratio (30.20) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 32.12
Quick Ratio 30.2
NN6.DE Yearly Current Assets VS Current LiabilitesNN6.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. NN6.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 41.99% over the past year.
  • The Revenue has grown by 43.94% in the past year. This is a very strong growth!
  • NN6 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.69% yearly.
EPS 1Y (TTM)41.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.57%
Revenue 1Y (TTM)43.94%
Revenue growth 3Y-69.83%
Revenue growth 5Y29.69%
Sales Q2Q%36.99%

3.2 Future

  • Based on estimates for the next years, NN6 will show a very strong growth in Earnings Per Share. The EPS will grow by 41.42% on average per year.
  • Based on estimates for the next years, NN6 will show a very strong growth in Revenue. The Revenue will grow by 104.39% on average per year.
EPS Next Y-1.96%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year232.78%
Revenue Next 2Y104.39%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NN6.DE Yearly Revenue VS EstimatesNN6.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
NN6.DE Yearly EPS VS EstimatesNN6.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2025 -0.05 -0.1 -0.15 -0.2

More info and screens

Find the best growth stocksShow best growing peers

1

4. NN6.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • NN6 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NN6.DE Price Earnings VS Forward Price EarningsNN6.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NN6.DE Per share dataNN6.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as NN6's earnings are expected to grow with 41.42% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. NN6.DE Dividend Analysis

5.1 Amount

  • NN6 has a Yearly Dividend Yield of 6.98%, which is a nice return.
  • NN6's Dividend Yield is rather good when compared to the industry average which is at 1.16. NN6 pays more dividend than 100.00% of the companies in the same industry.
  • NN6's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
Industry RankSector Rank
Dividend Yield 6.98%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
NN6.DE Yearly Dividends per shareNN6.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 0.1 0.2 0.3 0.4

5.3 Sustainability

DPN/A
EPS Next 2Y41.42%
EPS Next 3YN/A
NN6.DE Yearly Income VS Free CF VS DividendNN6.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

More info and screens

Find the best dividend stocksShow peers with best dividend

NN6.DE Fundamentals: All Metrics, Ratios and Statistics

NANOREPRO AG

FRA:NN6 (4/10/2026, 7:00:00 PM)

1.415

-0.03 (-2.41%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners9.02%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.25M
Revenue(TTM)5.13M
Net Income(TTM)-1.72M
Analysts84
Price Target4.59 (224.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.98%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.56
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.54
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.4
BVpS2.89
TBVpS2.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.54%
ROE -4.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.36%
FCFM N/A
ROA(3y)-8.02%
ROA(5y)5.73%
ROE(3y)-8.27%
ROE(5y)9.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y21.22%
GM growth 5Y-10.72%
F-ScoreN/A
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 32.12
Quick Ratio 30.2
Altman-Z 16.09
F-ScoreN/A
WACC7.45%
ROIC/WACCN/A
Cap/Depr(3y)12370.7%
Cap/Depr(5y)7428.72%
Cap/Sales(3y)5.57%
Cap/Sales(5y)3.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.99%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%27.57%
EPS Next Y-1.96%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)43.94%
Revenue growth 3Y-69.83%
Revenue growth 5Y29.69%
Sales Q2Q%36.99%
Revenue Next Year232.78%
Revenue Next 2Y104.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y49.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.28%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y192.54%
FCF growth 3Y4.96%
FCF growth 5YN/A
OCF growth 1Y196.07%
OCF growth 3Y6.28%
OCF growth 5YN/A

NANOREPRO AG / NN6.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NANOREPRO AG (NN6.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to NN6.DE.


What is the valuation status of NANOREPRO AG (NN6.DE) stock?

ChartMill assigns a valuation rating of 1 / 10 to NANOREPRO AG (NN6.DE). This can be considered as Overvalued.


How profitable is NANOREPRO AG (NN6.DE) stock?

NANOREPRO AG (NN6.DE) has a profitability rating of 1 / 10.


Can you provide the financial health for NN6 stock?

The financial health rating of NANOREPRO AG (NN6.DE) is 9 / 10.